CGEM PDUFA date: CLN-081
166 business days to decision · 2027-02-27
Cullinan Therapeutics, Inc.'s CLN-081 for Non Small Cell Lung Cancer — FDA decision expected February 27, 2027.
Key facts
PDUFA date2027-02-27
Business days away166
Drug / candidateCLN-081
IndicationNon Small Cell Lung Cancer
CompanyCullinan Therapeutics, Inc.
Market-cap tierSmall
Cohort decision-day move (history)±3% median
Cohort move is the historical median absolute decision-day move for this market-cap tier — history, not a prediction. See the full 2026 PDUFA calendar →
Not affiliated with or endorsed by the FDA. Informational and educational only — not investment advice. Verify against primary FDA / SEC / company filings. © 2026 pdufa.bio